November 28, 2017 / 9:33 PM / 20 days ago

BRIEF-Titan Pharmaceuticals Says Co​ Entered Into A Binding Term Sheet With L. Molteni & C. Dei F.Lli Alitti Societ*I Esercizio

Nov 28 (Reuters) - Titan Pharmaceuticals Inc:

* TITAN PHARMACEUTICALS INC - ON NOV 27, CO​ ENTERED INTO A BINDING TERM SHEET WITH L. MOLTENI & C. DEI F.LLI ALITTI SOCIET*I ESERCIZIO - SEC FILING

* TITAN PHARMACEUTICALS-‍PURSUANT TO AGREEMENT, CO WILL GRANT MOLTENI AN EXCLUSIVE RIGHT AND LICENSE TO COMMERCIALIZE PROBUPHINE IN EUROPEAN UNION​

* TITAN PHARMACEUTICALS INC - ‍TITAN AND MOLTENI EXPECT TO ENTER INTO DEFINITIVE LICENSE AND DISTRIBUTION AGREEMENT DURING Q1 OF 2018​ Source text: [bit.ly/2AcvxbE] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below